Kizaki M - Search Results

1

Multicenter prospective study of clonal complications in adult aplastic anemia patients following recombinant human granulocyte colony-stimulating factor (lenograstim) administration.

Bessho M, Hotta T, Ohyashiki K, Takahashi T, Mizoguchi H, Asano S, Ikeda Y, Sakurai M, Tojo A, Kizaki M, Iwanaga M, Tomonaga M, Hirashima K. Bessho M, et al. Among authors: kizaki m. Int J Hematol. 2003 Feb;77(2):152-8. Int J Hematol. 2003. PMID: 12627850 Clinical Trial.

2

Long-term administration of pegylated recombinant human megakaryocyte growth and development factor dramatically improved cytopenias in a patient with myelodysplastic syndrome.

Kizaki M, Miyakawa Y, Ikeda Y. Kizaki M, et al. Br J Haematol. 2003 Sep;122(5):764-7. doi: 10.1046/j.1365-2141.2003.04504.x. Br J Haematol. 2003. PMID: 12930386 Free article.

3

Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature.

Sato N, Nakazato T, Kizaki M, Ikeda Y, Okamoto S. Sato N, et al. Among authors: kizaki m. Int J Hematol. 2004 Feb;79(2):147-51. doi: 10.1532/ijh97.03137. Int J Hematol. 2004. PMID: 15005342 Review.

4

Granulocyte colony stimulating factor-producing multiple myeloma associated with neutrophilia.

Kohmura K, Miyakawa Y, Kameyama K, Kizaki M, Ikeda Y. Kohmura K, et al. Among authors: kizaki m. Leuk Lymphoma. 2004 Jul;45(7):1475-9. doi: 10.1080/10428190310001645870. Leuk Lymphoma. 2004. PMID: 15359652

5

Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: does body weight matter?

Kanda Y, Okamoto S, Tauchi T, Kizaki M, Inokuchi K, Yabe M, Yokoyama K, Ito Y, Kimura Y, Higashihara M, Bessho M, Ando K, Chiba S, Kurokawa M, Oshimi K, Dan K, Ohyashiki K, Ikeda Y; Tokyo STI Study Group (TSSG). Kanda Y, et al. Among authors: kizaki m. Am J Hematol. 2008 Nov;83(11):835-9. doi: 10.1002/ajh.21274. Am J Hematol. 2008. PMID: 18785644 Free article. Clinical Trial.

6

Exaggerated cutaneous response to mosquito bites in a patient with chronic lymphocytic leukemia.

Asakura K, Kizaki M, Ikeda Y. Asakura K, et al. Among authors: kizaki m. Int J Hematol. 2004 Jul;80(1):59-61. doi: 10.1532/ijh97.04021. Int J Hematol. 2004. PMID: 15293569

7

Multilineage involvement of light microscopic myeloperoxidase-negative acute leukemia.

Iguchi T, Yamada Y, Awaya N, Ikeda Y, Okamoto S, Kizaki M. Iguchi T, et al. Among authors: kizaki m. Int J Hematol. 2005 Nov;82(4):315-8. doi: 10.1532/IJH97.05062. Int J Hematol. 2005. PMID: 16298822

8

Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma.

Tanosaki R, Okamoto S, Akatsuka N, Ishida A, Michikawa N, Masuda Y, Uchida H, Murata M, Kizaki M, Ikeda Y. Tanosaki R, et al. Among authors: kizaki m. Cancer. 1994 Oct 1;74(7):1939-44. doi: 10.1002/1097-0142(19941001)74:7<1939::aid-cncr2820740719>3.0.co;2-c. Cancer. 1994. PMID: 7521788 Clinical Trial.

9

Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways.

Sawafuji K, Miyakawa Y, Kizaki M, Ikeda Y. Sawafuji K, et al. Among authors: kizaki m. Am J Hematol. 2003 Jan;72(1):67-9. doi: 10.1002/ajh.10245. Am J Hematol. 2003. PMID: 12508271 Free article.

10

A novel therapeutic approach for hematological malignancies based on cellular differentiation and apoptosis.

Kizaki M, Nakazato T, Ito K, Kawamura C, Miyakawa Y, Ikeda Y. Kizaki M, et al. Int J Hematol. 2002 Aug;76 Suppl 1:250-2. doi: 10.1007/BF03165253. Int J Hematol. 2002. PMID: 12430859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters